The Johns Hopkins University Data Science and AI Institute welcomes applications for its Postdoctoral Fellowship program, seeking disciplinarily diverse scholars to advance foundational methods of ...

Johns Hopkins University has significantly scaled back its diversity initiatives, including ending hiring programs and reducing staff, following federal pressure and institutional caution. New ...

Desai previously served as the Johns Hopkins Myron L. Weisfeldt Professor of Medicine, director of the Osler Medical ...

Maryland has some of the highest cases of Lyme disease​ in the nation, yet funding for research is in jeopardy.

Five hundred fifty-three students from 10 countries, 45 states, the District of Columbia, and Puerto Rico were admitted to Johns Hopkins University today. These first members of the undergraduate ...

Great Learning, a leading global edtech company, has launched the AI in Healthcare program in collaboration with Johns Hopkins University (JHU), a globally top-ranked university in medicine and public ...

The New Haven private school received the $50 million donation from businessman and billionaire John C. Malone, who graduated ...

Jasmine, a Bradenton teenager, has been recovering for weeks after what the hospital describes as life-saving surgery.

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets TRBC2-positive T-cell cancers, expanding a precision approach they established ...

Soon after President Donald Trump’s inauguration, staff at Johns Hopkins University’s diversity office were called into a meeting. The message was brief and unsettling. Because of a new White House ...

Back from ASH 2025, Dr Suchitra Sundaram reports on notable frontline CLL data. Time‑limited pirtobrutinib combined with venetoclax and obinutuzumab produced high rates of undetectable minimal ...

Nurix Therapeutics recently reported Phase 1 data showing its BTK degrader bexobrutideg (NX-5948) achieved a 75% objective response rate in patients with relapsed or refractory Waldenström ...